Coherus BioSciences Inc reports results for the quarter ended in September 30 - Earnings Summary

Coherus Oncology

07/11/2024 04:26

* Coherus BioSciences Inc  CHRS.OQ  reported a quarterly
adjusted
loss of 1 cent​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -27 cents.  The mean expectation of
nine analysts for the quarter was for a loss of 12 cents per
share. Wall Street expected results to range from -28 cents to 2
cents per share.
    * Revenue fell 5.1% to $70.77 million from a year ago;
analysts
expected $59.23 million. 
    * Coherus BioSciences Inc's reported EPS for the quarter was
a
loss of 9 cents​.
    * The company reported a quarterly loss of $10.75 million.
    * Coherus BioSciences Inc shares had fallen by 29.7% this
quarter and lost 78.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 7.9%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Coherus
BioSciences Inc is 8.00 
This summary was machine generated from LSEG data November 7 at
04:26 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.12          -0.01          Beat
 Jun. 30 2024      -0.29          -0.14          Beat
 Mar. 31 2024      -0.24          -0.32          Missed
 Dec. 31 2023      -0.12          -0.62          Missed